DETASEME
DETASEMEN N KESEHKESEHAATAN TAN WILWILAAYAH YAH MALAMALANGNG RUMAH SAKIT TINGKAT III BALADHIKA HUSADA RUMAH SAKIT TINGKAT III BALADHIKA HUSADA
PROGRAM KERJA
PROGRAM KERJA
tentang
tentang
TIM PPRA
TIM PPRA
RUMKIT TK. III BALADHIKA HUSADA
RUMKIT TK. III BALADHIKA HUSADA
DISAHKAN DENGAN SURAT KETETAPAN KARUMKIT TK III BALADHIKA HUSADA DISAHKAN DENGAN SURAT KETETAPAN KARUMKIT TK III BALADHIKA HUSADA
Nomor
DETASEMEN KESEHATAN WILAYAH MALANG RUMAH SAKIT TINGKAT III BALADHIKA HUSADA
PROGRAM KERJA
tentang
TIM PPRA
RUMKIT TK. III BALADHIKA HUSADA
DISAHKAN DENGAN SURAT KETETAPAN KARUMKIT TK III BALADHIKA HUSADA Nomor SK/ /X/2018 TANGGAL DESEMBER 2018
LEMBAR PENGESAHAN
PENGESAHAN DOKUMEN RUMAH SAKIT TINGKAT III BALADHIKA HUSADA
PROGRAM KERJA TIM PPRA
NAMA JABATAN TANDA
TANGAN TANGGAL
dr. A! "#$r!%&'%(o S).B K#*+% T!m PPRA
Mo,'%m%d B!-r! S.K.M.
K%)*#( &m NRP 21800810133 K%+r*++d
dr. M%&-+m P%(d#4!m% S).OT.
DAFTAR ISI
S+r%* K#*#*%)%( K#)%4% R+m%' S%&!* T!(6&%* III B%4%d'!&% H+-%d% Nomor SK/77/ 7./7..*%(66%4 *#(*%(6 Pro6r%m K#r% T!m PPRA
BAB I PENDAHULUAN... 3 BAB II LATAR BELAKANG... 3 BAB III TUJUAN...4 1.TUUAN UMUM... 2.TUUAN KHUSUS... BAB IV KEGIATAN POKOK DAN RINCIAN KEGIATAN...4 BAB V CARA MELAKSANAKAN KEGIATAN...5 BAB VI SASARAN... BAB VII JAD!AL PELAKSANAAN KEGIATAN... BAB VIII EVALUASI PELAKSANAAN KEGIATAN DAN PELAPORAN... BAB I" PENCATATAN# PELAPORAN DAN EVALUASI KEGIATAN...$
DETASEMEN KESEHATAN WILAYAH MALANG RUMAH SAKIT TINGKAT III BALADHIKA HUSADA
SURAT KETETAPAN
KEPALA RUMAH SAKIT TINGKAT III BALADHIKA HUSADA NOMOR SK/ / /2018
T#(*%(6 PROGRAM KERA
TIM PENGENDALIAN RESISTENSI ANTIMIKROBA K#)%4% R+m%' S%&!* T!(6&%* I!! B%4%d'!&% H+-%d%
M#(!m$%( 6
9 %. $%':% )#(!(6&%*%( &#%d!%( d%( )#(;#$%r%( m!&ro$% ;%(6 r#-!-*#( *#r'%d%) %(*!m!&ro$% d! r+m%' -%&!* d!-#$%$&%( o4#' )#(66+(%%( %(*!m!&ro$% ;%(6 *!d%& $!%& d%( r#(d%'(;% &#*%%*%( *#r'%d%) &#:%-)%d%%( -*%(d%r< $. $%':% d%4%m r%(6&% m#(6#(d%4!&%( m!&ro$% r#-!-*#( d! r+m%' -%&!* d!)#r4+&%( %d%(;% )#dom%( &#r% *!m )#4%&-%(% )ro6r%m )#(6#(d%4!%( r#-!-*#(-! %(*!m!&ro$% d! r+m%' -%&!*<d%(
,. $%':% -#'+$+(6%( d#(6%( '%4 *#r-#$+* d! %*%- )#r4+
d!*#*%)&%( d#(6%( K#*#*%)%(K#)%4%R+m%' S%&!*.
M#(6!(6%* 9 1. U(d%(6=+(d%(6R#)+$4!& I(do(#-!% Nomor 2 *%'+(
200 *#(*%(6Pr%&*!& K#do&*#r%(<
2. U(d%(6=+(d%(6R#)+$4!& I(do(#-!% Nomor > *%'+(
200 *#(*%(6K#-#'%*%(<
. U(d%(6=U(d%(6 R#)+$4!& I(do(#-!% Nomor *%'+(
200 *#(*%(6 R+m%' S%&!*<
. P#r%*+r%( M#(*#r! K#-#'%*%( R#)+$4!& I(do(#-!% Nomor
20> *%'+( 2011 *#(*%(6 P#dom%( Um+m P#(66+(%%( A(*!$!o*!& <
5. P#r%*+r%(M#(*#r!K#-#'%*%(R#)+$4!& I(do(#-!% Nomor
5> *%'+( 201 *#(*%(6R+m%' S%&!*<d%(
2 *%'+( 2015 *#(*%(6Pro6r%m P#(6#(d%4!%( R#-!-*#(-! A(*!m!&ro$% d! R+m%' S%&!*< MENETAPKAN M#(#*%)&% (
9 1. S+r%* K#*#*%)%(&#)%4% R+m%' S%&!* T#(*%(6 P#dom%(
K#r% T!m P#4%&-%(% Pro6r%m P#(6#(d%4!%( R#-!-*#(-! A(*!m!&ro$%
2. P#dom%( K#r% T!m P#4%&-%(% Pro6r%m P#(6#(d%4!%(
R#-!-*#(-! A(*!m!&ro$% d! R+m%' S%&!* -#$%6%!m%(% *#r4%m)!r d%4%m K#*#*%)%(!(!.
. P#dom%( K#r% T!m P#4%&-%(% Pro6r%m P#(6#(d%4!%(
R#-!-*#(-! A(*!m!&ro$% d! R+m%' S%&!* d!6+(%&%( d%4%m )#(6#(d%4!%( r#-!-*#(-! %(*!m!&ro$% d! R+m%' S%&!*.
. K#*#*%)%(!(! $#r4%&+ -#%& *%(66%4 d!*#*%)&%( d%( %)%$!4% d! &#m+d!%( '%r! *#r(;%*% *#rd%)%* &#!r+%( d%4%m &#*#*%)%( !(! %&%( d!%d%&%( )#r$%!&%( -#$%6%!m%(% m#-*!(;%.
D!*#*%)&%( d! #m$#r
)%d% *%(66%4 O&*o$#r 2018
K%r+m&!*T&. III B%4%d'!&% H+-%d%
dr. M%&-+m P%(d#4!m% S).OT.
4
DETASEMEN KESEHATAN WILAYAH MALANG RUMAH SAKIT TINGKAT III BALADHIKA HUSADA
L%m)!r%( SK K%r+m&!* T&.III B%4%d'!&% H+-%d% Nomor SK/ /X/2018 T%(66%4 O&*o$#r 2018 PROGRAM KERJA tentang TIM PPRA
RUMKIT TK.III BALADHIKA HUSADA
BAB I PENDAHULUAN
D%4%m r%(6&% )#4%&-%(%%( PPRA d! r+m%' -%&!* m%&% )#r4+ d!-+-+( -+%*+ )ro6r%m )#4%&-%%( )#(6#(d%4!%( r#-!-*#(-! %(*!m!&ro$% d! r+m%' -%&!* B%4%d'!&% H+-%d%.
BAB II
LATAR BELAKANG
R#-!-*#(-! m!&ro$% *#r'%d%) %(*!m!&ro$% *#4%' m#(%d! m%-%4%' &#-#'%*%( ;%(6 m#(d+(!% d#(6%( $#r$%6%! d%m)%& m#r+6!&%( d%)%* m#(+r+(&%( m+*+ )#4%;%(%( &#-#'%*%(. M+(,+4 d%( $#r&#m$%(6(;% r#-!-*#(-! %(*!m!&ro$% *#r%d! &%r#(% *#&%(%( -#4#&-! ;%(6 -%(6%* $#r'+$+(6%( d#(6%( )#(66+(%%( %(*!m!&ro$% d%( )#(;#$%r%( m!&ro$% r#-!-*#(. T#&%(%( -#4#&-! r#-!-*#(-! d%)%* d!'%m$%* d#(6%( ,%r% m#(66+(%&%( -#,%r% $!%& -#d%(6&%( )ro-#- )#(;#$%r%( d%)%* d!'%m$%* d#(6%( ,%r% m#(6#(d%4!&%( !(?#&-! -#,%r% o)*!m%4.
R#-!-*#(-! %(*!m!&ro$% ;%(6 d!m%&-+d %d%4%' r#-!-*#(-! *#r'%d%) %(*!m!&ro$% ;%(6 #?#&*!? +(*+& *#r%)! !(?#&-! ;%(6 d!-#$%$&%( o4#' $%&*#r! %m+r @!r+- d%( )%r%-!*. B%&*#r! %d%4%' )#(;#$%$ !(?#&-! *#r$%(;%& m%&% )#(66+(%%( %(*!$%&*#r! ;%(6 d!m%&-+d %d%4%' )#(66+(%%( %(*!$!o*!&.
B#r$%6%! ,%r% )#r4+ d!4%&+&%( +(*+& m#(%(66+4%(6! m%-4%' r#-!-*#(-! %(*!m!&ro$% !(! $%!& d! *!(6&%* )#ror%(6%( m%+)+( d! *!(6&%* !(-*!*+-! %*%+ 4#m$%6% )#m#r!(*%'%( d%4%m &#r%-%m% %(*%r=!(-*!*+-! m%+)+( %(*%r=(#6%r%. WHO *#4%' $#r'%-!4 m#r+m+-&%( >3 r#&om#(d%-! $%6! (#6%r% %(66o*% +(*+& m#4%&-%(%&%( )#(6#(d%4!%( r#-!-*#(-! %(*!m!&ro$%. D! !(do(#-!% r#&om#(d%-! !(! *%m)%&(;% $#4+m *#r4%&-%(% -#,%r% !(-*!*+-!o(%4. P%d%'%4 -+d%' d!&#*%'+! $%':% )#(%(66+4%(6%( m%-%4%' r#-!-*#(-! %(*!m!&ro$% d! *!(6&%* !(*#r(%-!o(%4 '%(;% d%)%* d!*+(*%-&%(
5
m#4%4+! 6#r%&%( 64o$%4 ;%(6 d!4%&-%(%&%( -#,%r% -#r#(*%& *#r)%d+ d%( $#r-!(%m$+(6 d%r! -#m+% (#6%r%. D!)#r4+&%( )#m%'%m%( d%( &#;%&!(%( *#(*%(6 %d%(;% m%-%4%' r#-!-*#(-! %(*!m!&ro$% ;%(6 &#m+d!%( d!4%(+*&%( d#(6%( 6#r%&%( (%-!o(%4 m#4%4+! )ro6r%m *#r)%d+ %(*%r% r+m%' -%&!* )ro?#-! &#-#'%*%( m%-;%r%&%* )#r+-%'%%( ?%rm%-! d%( )#m#r!(*%' d%#r%' d!$%:%' &oord!(%-! )#m#r!(*%' )+-%* m#4%4+! &#m#(*#r!%( &#-#'%*%(. G#r%&%( )#(%(66+4%(6%( d%( )#(6#(d%4!%( r#-!-*#(-! %(*!m!&ro$% -#,%r% )%r!)+r(% !(! d!-#$+* d#(6%( Pro6r%m P#(6#(d%4!%( R#-!-*#(-! A(*!m!&ro$% PPRA.
BAB III TUJUAN
%. T&'&an U(&( )an T&'&an K*&+&+
%. T++%( Um+m
1 M#(#&%( r#-!-*#(-! %(*!$!o*!&
2 M#(,#6%' *o&-!-!*%- %&!$%* )#(66+(%%( %(*!$!o*!&
M#(+r+(&%( $!%;% %&!$%* )#(66+(%%( %(*!$!o*!& ;%(6 *!d%& $!%& M#(+r+(&%( r!-!&o !(?#&-! (o-o&om!%4
$. T++%(
K'+-+-1 M#(!(6&%*&%( )#(6#*%'+%( d%( :%:%-%( m#(6#(%! PPRA
2 M#(d%)%*&%( 6%m$%r%( )o4% )#(66+(%%( %(*!$!o*!& d! R+m%' S%&!* M#(d%)%*&%( 6%m$%r%( )o4% r#-!-*#(-! %(*!m!&ro$% d! R+m%' -%&!*
M#(#&%( m+(,+4(;% Multi Drug Resisten
5 M#(6#*%'+! *!(6&%* &#$#r'%-!4%( )#4%&-%(%%( )ro6r%m
BAB IV
KEGIATAN POKOK DAN RINCIAN KEGIATAN
K#6!%*%( )o&o& d%( r!(,!%( !%*%( )ro6r%m !(! *#rd!r! d%r! 9
%. So-!%4!-%-! d%( )#4%*!'%( -*%? *#(%6% &#-#'%*%( *#(*%(6 )#(6#(d%4!%(
r#-!-*#(-! %(*!m!&ro$%
1 So-!%4!-%-! *#r'%d%) -#4+r+' %(66o*% r+m%' -%&!* m#(6#(%! PPRA
2 So-!%4!-%-! *#r'%d%) do&*#r r+m%' -%&!*
P#m$+%*%( m#d!% !(?orm%-! m#(6#(%! PPRA 4#%?4#* )%m?4#* d44
$. S+r@#!4#(- )o4% )#(66+(%%( %(*!$!o*!& d! r+m%' -%&!*
1 M#(6+m)+4&%( d%*% )#(66+(%%( %(*!$!o*!& ;%(6 d!6+(%&%(
2 M#m$+%* )o4% )#(66+(%%( %(*!$!o*!&
M#4%&+&%( #@%4+%-! *#r'%d%) )#(66+(%%( %(*!$!o*!&
,. S+r@%!4#(- )o4% r#-!-*#(-! %(*!m!&ro$% d#(6%( m#(66+(%&%( m#*od#
1 M#(6+m)+4&%( d%*% )#m#r!&-%%( &+4*+r d%( r#-!-*#(-! %(*!$!o*!& 2 M#m$+%* r#&%)%( '%-!4 &+4*+r d#(6%( &+m%( )o-!*!?
6
M#m$+%* )o4% %(*!m!&ro$%
d. M#(6%d%&%( ?or+m &%!%( !(?#&-! *#r!(*#6r%-!
1 "or+m &%!%( d!4%&-%(%&%( !&% d!*#m+&%( %d%(;% &%-+- *#r*#(*+ ;%(6 )#r4+ d!$%'%- -#,%r% &'+-+- d%4%m ?or+m
2 "or+m &%!%( d!4%&-%(%&%( $#r-%m% *!m )r%&*!-! &#-#'%*%( 4%!((;% #. M#4%&-%(%&%( Pro6r%m M+*+
1 M#4%&+&%( )#(6+m)+4%( d%*% )#(66+(%%( %(*!$!o*!&
2 M#4%&+&%( )#(6o4%'%( d%*% +(*+& )#r'!*+(6%( DDD d%( 6;--#(- M#4%&+&%( #@%4+%-! *#r'%d%) '%-!4 DDD d%(
G;--#(-BAB V
CARA MELAKSANAKAN KEGIATAN
1. So-!%4!-%-! d%( )#4%*!'%( -#r*% )#m$#r!%( :%:%-%( *%m$%'%( m#(6#(%!
)#(6#(d%4!%( r#-!-*#(-! %(*!m!&ro$% d!4%&+&%( d#(6%( ,%r% 9
%. So-!%4!-%-! m#(6#(%! PPRA -#*#4%' !%*%( %)#4 )%6! d! %+4%
&#)%d% -#4+r+' %(66o*% r+m%' -%&!*
$. So-!%4!-%-! &#)%d% do&*#r r+m%' -%&!* )%d% -%%* mor(!(6 r#)or*
,. B#r&oord!(%-! d#(6%( MIRM m#(6#(%! )#m$+%*%( m#d!% !(?orm%-!
PPRA
d. M#(;!m)%( M#d!% I(?orm%-! d! $#$#r%)% *#m)%* d! %r#% R+m%' S%&!*
2. S+r@#!4#(-# )o4% )#(66+(%%( %(*!$!o*!& d! r+m%' -%&!* d!4%&+&%( d#(6%( ,%r% 9
%. B#r&oord!(%-! d#(6%( r+%(6%( *#r&%!* *#(*%(6 )#(66+(%%( %(*!$!o*!& $. M#(,%r! d%*% d%r! r#&%m m#d!- )%-!#( ;%(6 m#(66+(%&%( %(*!$!o*!& d! r+%(6%( *#r&%!*
,. M#m$+%* )o4% )#(66+(%%( %(*!$!o*!&
. M#(6%d%&%( ?or+m &%!%( !(?#&-! *#r!(*#6r%-! $#r-%m% *!m )r%&*!-! &#-#'%*%( 4%!((;% -#,%r% $#r&%4%.
%. I-! d%r! ?or+m &%!%( d!4%&+&%( d#(6%( )#m$%'%-%( ;%(6 *#rd!r! d%r!
1 G+!d#4!(# $%-#d d#,!-!o(
2 D!%6(o-!- )%-*! &4!(!- L%$ Ro(*6#( M#(#(*+&%( d#r%%* &#)%r%'%(
&%-+-$. P#m$%'%-%( %(*!$!o*!&CM!&ro$!o4o6! #(!- r+*# do-!- d+r%-! mo(!*or!(6
1 M#(#(*+&%( )%r%m#*#r o$-#r@%-!
2 M#4%&+&%( )#4%)or%( '%-!4 )#r*#m+%( ?or+m d. M#4%&-%(%&%( )ro6r%m m+*+
1 P#(6+m)+4%( d%*% )#(66+(%%( %(*!$!o*!&
2 M#4%&+&%( )#(6o4%'%( d%*% +(*+& )#r'!*+(6%( ddd d%( 6;--#(- M#4%&+&%( #@%4+%-! *#r'%d%) '%-!4 ddd d%(
6;--#(-7
BAB VI
JAD!AL PELAKSANAAN KEGIATAN
No. K#6!%*%( B+4%( 2018
%( "#$ M%r A)r M#! +( +4 A6- S#)* O&* No@ 1. So-!%4!-%-! %. &#)%d% %(66o*% RS $.K#)%d% Do&*#r RS ,.)#m$+%*%( m#d!% !(?orm%-! 2. S+r@#!4%(- Po4% A(*!$!o*!& %.M#(6+m)+4&%( d%*% )#(66+(%%( %(*!$!o*!& $.m#m$+%* )o4% )#(66+(%%( %(*!$!o*!& ,.m#m$+%* #@%4+%-! )#(66+(%%( %(*!$!o*!& . S+r@#!4%(- Po4% A(*!m!&ro$% %.m#(6+m)+4&%( d%*% )#m#r!&-%%( &+4*+r $.M#m$+%* r#&%)%( '%-!4 &+4*+r d#(6%( &+m%( )o-!*!? ,.m#m$+%* )o4% %(*!m!&ro$% M#(6%d%&%( ?or+m &%!%( . !(?#&-! *#r!(*#6r%-! %.*#m+%( &%-+- !(?#&-! $. &oord!(%-! d#(6%( *!m )r%&*!-! 4%!((;% 5. M#4%&-%(%&%( Pro6r%m M+*+ %. M#4%&+&%( )#(6+m)+4%( d%*% )#(66+(%%( %(*!$!o*!& $. M#4%&+&%( )#(6o4%'%( d%*% +(*+& )#r'!*+(6%( DDD d%( 6;--#(-BAB VI SASARAN
S%-%r%( !%*%( d%4%m Pro6r%m P#(6#(d%4!%( R#-!-*#(-! A(*!$!o*!& PPRA m#(6%,+ )%d% !(d!&%*or m+*+ ;%!*+9
8
M#(+r+((;% &o(-+m-! %(*!$!o*!& ;%!*+ $#r&+r%(6(;% +m4%' d%( #(!-%(*!$!o*!& ;%(6 d!6+(%&%( -#$%6%! *#r%)! #m)!r!- m%+)+( d#?!(!*!?
$. P#r$%!&%( &+%4!*%- )#(66+(%%( %(*!$!o*!&
M#(!(6&%*(;% )#(66+(%%( %(*!$!o*!& -#,%r% r%-!o(%4 &%*#6or! (o4 G;--#(- d%( m#(+r+((;% )#(66+(%%( %(*!$!o*!& *%()% !(d!&%-! &%*#6or! 4!m% G;--#(-
,. P#r$%!&%( )o4% -#(-!*!@!*%- %(*!$!o*!& d%( )#(+r+(%( m!&ro$% m+4*!r#-!-*#( ;%(6 *#r6%m$%r d%4%m )o4% &#)#&%%( %(*!$!o*!& -#,%r% )#r!od!& -#*!%) *%'+(
d. P#(+r+(%( %(6&% !(?#&-! r+m%' -%&!* ;%(6 d!-#$%$&%( o4#' m!&ro$%
m+4*!r#-!-*#( ,o(*o' Methicillin Resistant Staphylococcus aureus
MRSA) d%( $%&*#r! )#(6'%-!4 Extended Spectrum beta-lactamase (ESBL)
#. P#(!(6&%*%( m+*+ )#(%(6%(%( &%-+- !(?#&-! -#,%r% m+4*! d!-!)4!( m#4%4+! ?or+m &%!%( &%-+- !(?#&-! *#r!(*#6r%-!
BAB VIII
EVALUASI PELAKSANAAN KEGIATAN DAN PELAPORAN
E@%4+%-! )ro6r%m &#r% d!4%&-%(%&%( -#*!%) $+4%( -#&%4! +(*+& m#m%-*!&%( )ro6r%m &#r% *#r4%&-%(% -#-+%! %d:%4. E@%4+%-! m#4!$%*&%( &#*+% *!m PPRA d%( K#)%4% R+m%' S%&!*
BAB I"
PENCATATAN #PELAPORAN DAN EVALUASI KEGIATAN
P#(,%*%*%( )#4%&-%(%%( !%*%( )ro6r%m &#r% d!4%&+&%( -#*!%) $+4%( +(*+& d!4%)or&%( -#r*% d!#@%4+%-! -#*!%) $+4%(. L%)or%( d%( #@%4+%-! *%'+(%( d!-+-+(
9
-#*!%) %&'!r *%'+( d%( d!4%)or&%( &#)%d% KPRA Kom!*# P#(6#(d%4!%( R#-!-*#(-! A(*!m!&ro$%
D! *#*%)&%( d! 9 #m$#r
P%d% *%(66%4 9 01 O&*o$#r 2018
M#(6#*%'+!
K#)%4% R+m%' S%&!* T!(6&%* III B%4%d'!&% H+-%d% K#*+% T!m PPRA
dr. M%&-+m P%(d#4!m% S).Or* L#*&o4 &m NRP. 11300188030